Diabetes mellitus and COVID-19: Understanding the association in light of current evidence

doi:10.12998/wjcc.v9.i28.8327

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5920)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

489

WORD

204

HTML

3920

Figures (1-2)

312

Sum=4925

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

363

Download

632

Sum=995

Oct 6, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Oct 6, 2021; 9(28): 8327-8339
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8327

Diabetes mellitus and COVID-19: Understanding the association in light of current evidence

Saikat Sen, Raja Chakraborty, Pratap Kalita, Manash Pratim Pathak

Saikat Sen, Manash Pratim Pathak, Faculty of Pharmaceutical Science, Assam down town University, Guwahati 781026, Assam, India

Raja Chakraborty, Department of Pharmaceutical Technology, School of Medical Sciences, ADAMAS University, Kolkata 700 126, West Bengal, India

Pratap Kalita, Department of Pharmacy, Pratiksha Institute of Pharmaceutical Sciences, Guwahati 781026, Assam, India

Author contributions: Sen S designed the study; Sen S, Chakraborty R, Kalita P and Pathak MP carried out the literature search; S Sen, Kalita P and Pathak MP extracted the data from available literature; S Sen, Chakraborty R, Kalita P and Pathak MP were involved in drafting of the manuscript; S Sen and Chakraborty R provided further editing and comments.

Conflict-of-interest statement: Authors declare no conflict of interests for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Saikat Sen, PhD, Professor, Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati 781026, Assam, India. saikat.pharm@rediffmail.com

Received: March 6, 2021
Peer-review started: March 6, 2021
First decision: March 30, 2021
Revised: April 12, 2021
Accepted: July 29, 2021
Article in press: July 29, 2021
Published online: October 6, 2021

Core Tip

Core Tip: This review highlights the significant correlation between diabetes mellitus and coronavirus disease 2019 (COVID-19) in light of available published information. COVID-19 is responsible for increased risk and disease severity in diabetic patients. Cytokine storm, destruction of beta cells and the expression of angiotensin converting enzyme 2 are some of the fundamental mechanisms discussed. This review also summarizes the range of investigations that have been undertaken across a large set of published papers on COVID-19 and diabetes mellitus.